Mutations in the tumor suppressor gene p53 (TP53) represent the most prevalent genetic alterations observed in human cancers, occurring in over 50% of tumors and up to 80% in aggressive cancers like high-grade serous ovarian cancer and small-cell lung cancer [11,12]. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.